TrialAnnals of the rheumatic diseases2007

Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.

Mikiko Tokunaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.